216 related articles for article (PubMed ID: 30732952)
1. Obesity and genes related to lipid metabolism predict poor survival in oral squamous cell carcinoma.
Hu Q; Peng J; Chen X; Li H; Song M; Cheng B; Wu T
Oral Oncol; 2019 Feb; 89():14-22. PubMed ID: 30732952
[TBL] [Abstract][Full Text] [Related]
2. A Three Long Noncoding RNA-Based Signature for Oral Squamous Cell Carcinoma Prognosis Prediction.
Zhao C; Zou H; Wang J; Shen J; Liu H
DNA Cell Biol; 2018 Nov; 37(11):888-895. PubMed ID: 30234381
[TBL] [Abstract][Full Text] [Related]
3. The poor outcome of second primary oral squamous cell carcinoma is attributed to Bmi1 upregulation.
Hu Q; Wu T; Chen X; Li H; Du Z; Hao Y; Peng J; Tai S; Song M; Cheng B
Cancer Med; 2018 Apr; 7(4):1056-1069. PubMed ID: 29479858
[TBL] [Abstract][Full Text] [Related]
4. Construction of prognostic risk prediction model of oral squamous cell carcinoma based on co-methylated genes.
Zhu Q; Tian G; Gao J
Int J Mol Med; 2019 Sep; 44(3):787-796. PubMed ID: 31198983
[TBL] [Abstract][Full Text] [Related]
5. Seven-CpG-based prognostic signature coupled with gene expression predicts survival of oral squamous cell carcinoma.
Shen S; Wang G; Shi Q; Zhang R; Zhao Y; Wei Y; Chen F; Christiani DC
Clin Epigenetics; 2017; 9():88. PubMed ID: 28852427
[TBL] [Abstract][Full Text] [Related]
6. High expression of TROP2 is correlated with poor prognosis of oral squamous cell carcinoma.
Tang G; Tang Q; Jia L; Xia S; Li J; Chen Y; Li H; Ding X; Wang F; Hou D; Kuai X; Feng Z; Fan Y
Pathol Res Pract; 2018 Oct; 214(10):1606-1612. PubMed ID: 30098828
[TBL] [Abstract][Full Text] [Related]
7. Host Factors Independently Associated With Prognosis in Patients With Oral Cavity Cancer.
Valero C; Zanoni DK; Pillai A; Ganly I; Morris LGT; Shah JP; Wong RJ; Patel SG
JAMA Otolaryngol Head Neck Surg; 2020 Aug; 146(8):699-707. PubMed ID: 32525545
[TBL] [Abstract][Full Text] [Related]
8. The impact of pathologic close margin on the survival of patients with early stage oral squamous cell carcinoma.
Chen TC; Wang CP; Ko JY; Yang TL; Lou PJ
Oral Oncol; 2012 Jul; 48(7):623-8. PubMed ID: 22349276
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of BST2 is associated with nodal metastasis and poorer prognosis in oral cavity cancer.
Fang KH; Kao HK; Chi LM; Liang Y; Liu SC; Hseuh C; Liao CT; Yen TC; Yu JS; Chang KP
Laryngoscope; 2014 Sep; 124(9):E354-60. PubMed ID: 24706327
[TBL] [Abstract][Full Text] [Related]
10. [A novel prognostic index for oral cancer in Fujian province].
Wu JF; Lin LS; Chen F; Liu FQ; Yan LJ; Bao XD; Wang J; Wang R; Lin LK; Qiu Y; Zheng XY; Hu ZJ; Cai L; He BC
Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Jun; 39(6):841-846. PubMed ID: 29936758
[No Abstract] [Full Text] [Related]
11. Multicenter Retrospective Study of Adjuvant Therapy for Patients with Pathologically Lymph Node-Positive Oral Squamous Cell Carcinoma: Analysis of Covariance Using Propensity Score.
Yanamoto S; Otsuru M; Ota Y; Okura M; Aikawa T; Kurita H; Kamata T; Kirita T; Yamakawa N; Ueda M; Yamashita T; Komori T; Shigeta T; Yokoo S; Ogawa M; Umeda M;
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S992-9. PubMed ID: 26289809
[TBL] [Abstract][Full Text] [Related]
12. High HMGA2 Expression Correlates with Reduced Recurrence-free Survival and Poor Overall Survival in Oral Squamous Cell Carcinoma.
Fang CY; Liew PL; Chen CL; Lin YH; Fang CL; Chen WY
Anticancer Res; 2017 Apr; 37(4):1891-1899. PubMed ID: 28373457
[TBL] [Abstract][Full Text] [Related]
13. A two-CpG-based prognostic signature for oral squamous cell carcinoma overall survival.
Chen Y; Hei N; Zhao J; Peng S; Yang K; Chen H; Cui Z; Jin L; Sun R; Guo J
J Cell Biochem; 2019 Jun; 120(6):9082-9090. PubMed ID: 30548666
[TBL] [Abstract][Full Text] [Related]
14. Foxp3 overexpression in tumor cells predicts poor survival in oral squamous cell carcinoma.
Song JJ; Zhao SJ; Fang J; Ma D; Liu XQ; Chen XB; Wang Y; Cheng B; Wang Z
BMC Cancer; 2016 Jul; 16():530. PubMed ID: 27457382
[TBL] [Abstract][Full Text] [Related]
15. Increased placenta growth factor mRNA level is significantly associated with progression, recurrence and poor prognosis of oral squamous cell carcinoma.
Cheng SJ; Cheng SL; Lee JJ; Chen HM; Chang HH; Kok SH; Chiang ML; Kuo MY
J Formos Med Assoc; 2013 May; 112(5):253-8. PubMed ID: 23660220
[TBL] [Abstract][Full Text] [Related]
16. Reduced gamma-catenin expression and poor survival in oral squamous cell carcinoma.
Närkiö-Mäkelä M; Pukkila M; Lagerstedt E; Virtaniemi J; Pirinen R; Johansson R; Kosunen A; Lappalainen K; Hämäläinen K; Kosma VM
Arch Otolaryngol Head Neck Surg; 2009 Oct; 135(10):1035-40. PubMed ID: 19841345
[TBL] [Abstract][Full Text] [Related]
17. Staging significance of bone invasion in small-sized (4cm or less) oral squamous cell carcinoma as defined by the American Joint Committee on Cancer.
Kuk SK; Yoon HJ; Hong SD; Hong SP; Lee JI
Oral Oncol; 2016 Apr; 55():31-6. PubMed ID: 26880520
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of DHRS9 is associated with poor prognosis in oral squamous cell carcinoma.
Shimomura H; Sasahira T; Nakashima C; Shimomura-Kurihara M; Kirita T
Pathology; 2018 Oct; 50(6):642-647. PubMed ID: 30149992
[TBL] [Abstract][Full Text] [Related]
19. Ultra-deep targeted sequencing of advanced oral squamous cell carcinoma identifies a mutation-based prognostic gene signature.
Chen SJ; Liu H; Liao CT; Huang PJ; Huang Y; Hsu A; Tang P; Chang YS; Chen HC; Yen TC
Oncotarget; 2015 Jul; 6(20):18066-80. PubMed ID: 25980437
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Performance of a New Staging Category to Improve Discrimination of Disease-Specific Survival in Nonmetastatic Oral Cancer.
Lee CC; Huang CY; Lin YS; Chang KP; Chi CC; Lin MY; Su HH; Chang TS; Chen HC; Yang CC
JAMA Otolaryngol Head Neck Surg; 2017 Apr; 143(4):395-402. PubMed ID: 28125757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
